Prototyping 'intime' - a NINAAT-based self testing platform to detect infectious diseases

Informations projet

intime

N° de convention de subvention: 666852

DOI

10.3030/666852

Projet clôturé

Date de signature de la CE 26 Juin 2015

Date de début 1 Avril 2015

Date de fin 31 Mars 2019

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total

€ 4 526 324,00

Contribution de l’UE

€ 4 526 324,00

Coordonné par

SELFDIAGNOSTICS DEUTSCHLAND GMBH
Germany

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Droits de propriété intellectuelle

Patent (12)

METHOD AND ITS COMPOSITIONS FOR DETECTION OF NUCLEIC ACID TARGET FROM BIOLOGICAL SAMPLES AND BODY FLUIDS(Patent applicant is Selfdiagnostics OÜ, who has gave the right to Selfdiagnostics Deutschland GmbH to use the patent)

Numéro de demande/publication: US 20150322493A1
Date: 2015-04-20
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND ITS COMPOSITIONS FOR DETECTION OF NUCLEIC ACID TARGET FROM BIOLOGICAL SAMPLES AND BODY FLUIDS(Patent applicant is Selfdiagnostics OÜ, who has gave the right to Selfdiagnostics Deutschland GmbH to use the patent)

Numéro de demande/publication: CA 2888949
Date: 2015-04-21
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND RAPID TEST DEVICE FOR DETECTION OF TARGET MOLECULE(Patent applicant is Selfdiagnostics OÜ, who has gave the right to Selfdiagnostics Deutschland GmbH to use the patent)

Numéro de demande/publication: WO 2011095888A3
Date: 2011-01-28
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND ITS COMPOSITIONS FOR DETECTION OF NUCLEIC ACID TARGET FROM BIOLOGICAL SAMPLES AND BODY FLUIDS(Patent applicant is Selfdiagnostics OÜ, who has gave the right to Selfdiagnostics Deutschland GmbH to use the patent)

Numéro de demande/publication: AU 2013333763
Date: 2015-04-23
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND ITS COMPOSITIONS FOR DETECTION OF NUCLEIC ACID TARGET FROM BIOLOGICAL SAMPLES AND BODY FLUIDS(Patent applicant is Selfdiagnostics OÜ, who has gave the right to Selfdiagnostics Deutschland GmbH to use the patent)

Numéro de demande/publication: JP 2015-537284
Date: 2015-04-20
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

"""MICROFLUIDIC TEST SYSTEM, SAMPLE PLUG WITH SAMPLERECESSES AND RELATED METHOD"""

Numéro de demande/publication: PA 2017 70132
Date: 2017-02-22
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

MICROFLUIDIC TEST DEVICE

Numéro de demande/publication: PA 2017 70130
Date: 2017-02-22
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD FOR THE DETECTION OF A SEXUALLY TRANSMITTED INFECTIOUS PATHOGEN

Numéro de demande/publication: PCT /EP2016/081748
Date: 2016-12-19
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND RAPID TEST DEVICE FOR DETECTION OF TARGET MOLECULE

Numéro de demande/publication: EP 11714390
Date: 2011-01-28
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

"MICROFLUIDIC TEST SYSTEM, SAMPLE PLUG WITH SEALINGPART AND RELATED METHOD"""

Numéro de demande/publication: PA 2017 70131
Date: 2017-02-22
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND ITS COMPOSITIONS FOR DETECTION OF NUCLEIC ACID TARGET FROM BIOLOGICAL SAMPLES AND BODY FLUIDS.(Patent applicant is Selfdiagnostics OÜ, who has gave the right to Selfdiagnostics Deutschland GmbH to use the patent)

Numéro de demande/publication: WO 2014060604
Date: 2013-10-20
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

METHOD AND ITS COMPOSITIONS FOR DETECTION OF NUCLEIC ACID TARGET FROM BIOLOGICAL SAMPLES AND BODY FLUIDS

Numéro de demande/publication: EP 13792268
Date: 2013-10-20
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH

Trademark (1)

intime trademark

Numéro de demande/publication: EUTM 010305829
Date: 2012-02-14
Demandeur(s): SELFDIAGNOSTICS DEUTSCHLAND GMBH